We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 13.47%
3 Healthcare 12.09%
4 Consumer Discretionary 10.78%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAN
3451
DELISTED
eMagin Corporation
EMAN
$50K ﹤0.01%
21,824
EVFM
3452
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$50K ﹤0.01%
4,509
AQMS icon
3453
Aqua Metals
AQMS
$9.85M
$49K ﹤0.01%
118
HEPA
3454
DELISTED
Hepion Pharmaceuticals
HEPA
$49K ﹤0.01%
32
SRXH
3455
SRX Global
SRXH
$35.5M
$48K ﹤0.01%
+7
New +$52.3K
CYCN icon
3456
Cyclerion Therapeutics
CYCN
$16M
$48K ﹤0.01%
775
-5,706
-88% -$373K
VNRX icon
3457
VolitionRx Ltd
VNRX
$8.35M
$48K ﹤0.01%
769
ENZ
3458
DELISTED
Enzo Biochem, Inc.
ENZ
$48K ﹤0.01%
13,471
MLSS icon
3459
Milestone Scientific
MLSS
$42M
$47K ﹤0.01%
+24,916
New +$46.1K
TUSK icon
3460
Mammoth Energy Services
TUSK
$167M
$47K ﹤0.01%
15,843
LCI
3461
DELISTED
Lannett Company, Inc.
LCI
$47K ﹤0.01%
3,872
-32,750
-89% -$530K
CRBP icon
3462
Corbus Pharmaceuticals
CRBP
$185M
$46K ﹤0.01%
1,499
-15,668
-91% -$618K
SRGA
3463
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$46K ﹤0.01%
1,379
MRKR icon
3464
Marker Therapeutics
MRKR
$18.3M
$45K ﹤0.01%
2,656
TYME
3465
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$45K ﹤0.01%
42,998
TTOO
3466
DELISTED
T2 Biosystems, Inc
TTOO
$44K ﹤0.01%
10
SIOX
3467
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$44K ﹤0.01%
20,023
BOXL icon
3468
Boxlight
BOXL
$1.97M
$42K ﹤0.01%
13
AAIC
3469
DELISTED
Arlington Asset Investment Corp.
AAIC
$42K ﹤0.01%
11,092
LODE icon
3470
Comstock
LODE
$270M
$41K ﹤0.01%
1,498
ABEO icon
3471
Abeona Therapeutics
ABEO
$423M
$40K ﹤0.01%
1,411
SNCR
3472
DELISTED
Synchronoss Technologies
SNCR
$39K ﹤0.01%
1,762
-8,561
-83% -$210K
TONX
3473
TON Strategy Co
TONX
$174M
$39K ﹤0.01%
+2
New +$34K
AGTC
3474
DELISTED
Applied Genetic Technologies Corporation
AGTC
$39K ﹤0.01%
12,820
RESN
3475
DELISTED
Resonant Inc.
RESN
$39K ﹤0.01%
15,910

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.